Immunosuppression therapies including corticosteroids fail to prevent bronchiolitis obliterans syndrome (BOS), primarily a disease of the small airways, following lung transplantation. We reported increases in steroidresistant proinflammatory lymphocytes and their loss of histone deacetylase 2 (HDAC2), an important mediator of steroid action, in the blood of stable lung transplant recipients. We noted similar increases in the steroidresistant lymphocytes in both the blood and small airways in BOS compared with the large airways. We hypothesized that these small airway cells would also exhibit a loss of HDAC2, and that these changes could be reversed by treatment with theophylline (HDAC2 activator). Blood, bronchoalveolar lavage and large and small airway brushings were collected from lung transplant patients with BOS (n = 12) or stable lung function (n = 18) and healthy aged-matched controls (n = 13). 
Introduction
Immunosuppression therapy following lung transplant is inadequate at preventing chronic graft failure, with 5-year survival rates less than 60%, and bronchiolitis obliterans syndrome (BOS) developing in 50% of patients within the first 5 years post-transplant [1] . T helper type 1 (Th1) proinflammatory cytokines are known to be involved in transplant rejection, and are a target of current immunosuppression strategies [2] . Our previous studies showed inadequate immunosuppression of these cytokines in peripheral blood T and natural killer T-like cells (NK T-like) cells, particularly CD8 + cells, from stable lung transplant patients, even though systemic drug levels were within 'therapeutic range'. This finding suggested that measurement of intracellular T cell cytokines may provide a more physiological indication of immunosuppression than drug levels [3, 4] . The clinical relevance of these findings was further highlighted by an increase in proinflammatory cytokine levels with time post-transplant [5] and the further increase in patients with declining forced
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Corticosteroids switch off inflammatory genes by binding to the glucocorticoid receptor (GCR) and recruiting histone deacetylases (HDACs) to the inflammatory gene complex [9] . We recently showed that HDAC2 are decreased in peripheral blood proinflammatory T and NK T-like cells in lung transplant recipients and correlated with the proinflammatory potential of these cells, supporting a role for these mediators in steroid resistance in these patients [10] . Importantly, we showed a similar decrease in GCR in the small (distal) airways, but no changes in the large (proximal) airways [11] .
In the present study we further compared HDAC2 expression and intracellular proinflammatory cytokine production by CD8 + and CD8 -(CD4 + ) T, NK T-like and NK lymphocyte subsets in cultured peripheral blood, bronchoalveolar lavage (BAL), large and small airway brushings from stable lung transplant patients, patients with BOS and healthy controls using multi-parameter flow cytometry.
We hypothesized that steroid resistance in BOS is associated with increased proinflammatory cytokines and decreased HDAC2 in intraepithelial lymphocytes from the small airways compared with those from the large airways. We further hypothesized that treatment with theophylline, an HDAC2 activator [12] , would result in increased steroid responsiveness evident by an increase in HDAC2 expression and a decrease in proinflammatory cytokines in these steroid-resistant lymphocytes.
Materials and methods

Patient and control groups
Eighteen lung transplant recipients with no clinical or histopathological evidence of acute rejection or BOS, scheduled for routine surveillance assessment, were invited to participate in the study. Fully informed consent was obtained in accordance with institutional ethics approval. Demographic details of these patients are shown in Table 1 . Twelve patients with BOS, categorized both clinically and histologically on transbronchial biopsy according to standard criteria [1] (Table 1) were also recruited. All patients were investigated using the same protocol. All were tested to exclude cytomegalovirus [(CMV) histopathologically, rapid viral culture and CMV polymerase chain reaction (PCR) of BAL], mycoplasma (enzyme immunoassay of BAL), bacterial and fungal infection (BAL culture). Subjects were classified as A0B0 or A0BX and all were 17 ± 9·9 months [mean ± standard deviation (s.d.)] post-transplant.
Immunosuppression therapy comprised combinations of either cyclosporin A (CsA) or tacrolimus (Tac) with prednisolone [12 ± 3·6 mg/day (mean ± s.d.)] and azathioprine or mycophenolate mofetil. Trough plasma drug levels of either CsA or Tac were within or above recommended therapeutic ranges (ranges for CsA = 80-250 µg/l and Tac = 5-15 µg/l). Thirteen healthy age-matched volunteers were recruited as controls. Proximal and distal bronchial brushings were collected as previously reported [11] . Venous blood was collected into 10 U/ml preservative free sodium heparin (DBL, Sydney, Australia) and all samples were maintained at 4°C until processing. All authors were blinded to patient diagnoses at time of sampling, data acquisition and analyses.
Leucocyte counts
Full blood counts, including white cell differential counts, were determined on blood specimens using a CELL-DYN 4000 (Abbot Diagnostics, Sydney, Australia). Blood films and BAL cytospins were stained by the May-GrunwaldGiemsa method and leucocyte differential counts were checked microscopically by morphological assessment.
HDAC2 and intracellular cytokine expression in T and NK T-like cell subsets
To determine expression of HDAC2 and intracellular cytokine production in CD8 + and CD8 -T and NK T-like cells, aliquots of blood, BAL and proximal and distal airway brushings were stimulated as previously reported with phorbol myristate (25 ng/ml) (Sigma, Sydney, Australia) and ionomycin (1 µg/ml) (Sigma) in the presence of brefeldin A (1 µg/ml) (Sigma), and the tubes incubated in a humidified 5% CO 2 /95% air atmosphere at 37°C [11] . At 16 h, 100 µl 20 mM ethylenediamine tetraacetic acid/phosphate-buffered saline (EDTA/PBS) was added to the culture tubes, which were vortexed vigorously for 20 s to remove adherent cells. Samples were treated as previously reported and cells were analysed within 1 h on a FACSCanto II flow cytometer using FACSDiva software (BD Biosciences, North Ride, NSW, Australia) [10, 11] . Samples were analysed by gating lymphocytes using CD45 staining versus side-scatter (SSC). A minimum of 350 000 low SSC events were acquired in list-mode format for analysis. T cells, NK T-like cells and NK cells were identified as previously described [11] .
Effect of therapies on IFN-γ/TNF-α and HDAC2 expression
Doses of 5 mg/l theophylline (a dose previously shown not to cause significant side effects in patients) [12] and 1 µM prednisolone (standard therapeutic dose for patients) [13] were chosen, based on dose-response experiments of the effects of the drugs on intracellular interferon (IFN)-γ/tumour necrosis factor (TNF)-α synthesis by T, NK T-like and NK cells in peripheral blood. Aliquots of blood and small airway brushings were incubated with theophylline and/or prednisolone in 10 ml sterile tubes with equal volumes of RPMI + 10% fetal calf serum (FCS).
Cultures were then stimulated as for intracellular cytokine production, as described, for 16 h. Aliquots were then processed as for intracellular cytokines and HDAC2, IFN-γ and TNF-α expression, as described above.
Statistical analysis
Statistical analysis was performed using the Kruskal-Wallis and post-hoc analysis. Correlations were performed using Spearman's Rho correlation tests. spss software was applied and differences between groups of P < 0·05 considered significant.
Results
Blood lymphocytes
There was a significant decrease in 
BAL lymphocytes
In BAL, the percentages of CD3 + T cells and CD4 + T cells were decreased in BOS patients compared with control subjects. There was an increase in CD8 + T cells, NK T-like cells and NK cells in BOS patients compared with control subjects and CD8 + T cells in BOS patients compared with stable transplant [CD8 + T cells median (range) = BOS 64% (62-68), stable 46% (32-67), control 35% (15-79)].
Large airway brushing intraepithelial lymphocytes
The percentage of large airway brushing CD8 + intraepithelial lymphocytes was increased in patients with BOS compared with stable transplant [median (range) = BOS 79% (55-89), stable 56% (34-73), control 66% (33-81)]. There was a corresponding decrease in CD4 + intraepithelial lymphocytes in patients with BOS compared with stable transplant (data not shown). No other changes were noted in NK T-like cells and NK cells in the large airways (P > 0·05 for all) (data not shown). 
Small airway brushing intraepithelial lymphocytes
Proinflammatory cytokines and HDAC2 in blood lymphocytes
Proinflammatory cytokines and HDAC2 in BAL lymphocytes
The percentages of BAL CD8 + and CD8 -T cells producing IFN-γ and TNF-α were significantly increased in BOS patients compared with stable transplant patients and controls. There was an increase in the percentage of 
Proinflammatory cytokines and HDAC2 in large airway intraepithelial lymphocytes
There was a significant increase in the percentage of CD8 + T cells and NK cells producing IFN-γ and TNF-α in BOS patients compared with stable transplant and controls but no changes between stable transplant and controls (P > 0·05 for all) [median (range) CD8 + IFN-γ + T cells = BOS 78% (45-87), stable 64% (27-93), controls 53 (10-91), CD8 + TNF-α + T cells = BOS 79% (19-83), stable 66% (31-84), controls 54% (11-85), NK IFN-γ + T cells = BOS 82% (21-86), stable 40% (11-65), controls 32% (6-86), NK TNF-α + cell = BOS 85% (21-87), stable 39% (9-61), controls 44% (8-68)].
There was a significant decrease in the percentage of CD8 + T and NK cells expressing HDAC2 in patients with BOS compared with stable transplant and controls (P < 0·05 for all) ( Table 2) .
Proinflammatory cytokines and HDAC2 in small airway intraepithelial lymphocytes
IFN-γ and TNF-α were significantly increased in CD8 + T intraepithelial lymphocytes in patients with BOS compared with stable transplant patients and controls (P < 0·05 for all) and in stable transplant patients compared with controls (P < 0·05 for both) [median (range) = CD8 + IFN-γ + T cells = BOS 94% (78-98), stable 77% (31-91), control 29% (19-86), CD8 + TNF-α + T cells = BOS 97% (89-99), stable 78% (30-94), controls 34% (19-84)].
The percentages of IFN-γ and TNF-α in NK T-like and NK cells were significantly increased in BOS patients compared with stable transplant and control subjects (data not shown).
The percentage of CD8 + T cells and NK T-like cells expressing HDAC2 in BOS patients was significantly decreased compared with stable transplant and controls (P < 0·05 for all, Table 3 ).
IFN-γ/TNF-α expression and HDAC2 in small and large airway intraepithelial lymphocytes
There was a significant increase in the percentage of IFN-γ and TNF-α in CD8 + T cells in the small airways compared with the large airways in stable transplant and controls (data shown above (P < 0·05 for all). There was a significant increase in the percentage of CD8 + T and NK T-like cells in small airways compared with large airways in patients with BOS (P > 0·05 for both), but no difference between the percentage of CD8 + T cells producing IFN-γ and TNF-α in blood and small airways in patients with BOS. The percentage of HDAC2 CD8 + and CD4 + T cells and NK T-like cells was significantly decreased in small airway intraepithelial T cells compared with large airway intraepithelial T cells from patients with BOS (P < 0·05 for all, Tables 2 and 3) .
Correlation between IFN-γ/TNF-α by CD8 + intraepithelial T lymphocytes in small airway and patient FEV1/months post-transplant
In stable transplant patients the percentage of small airway CD8 + intraepithelial T cells from 18 patients expressing IFN-γ negatively correlated with FEV 1 (R = -0·465, P = 0·021). A significant correlation between months post-transplant and the percentage of small airway intraepithelial CD8 + T cells expressing IFN-γ (R = -0·378, P = 0·0039) was also shown for these stable transplants.
In BOS, there were significant negative correlations between the percentage of small airway CD8 + intraepithelial T cells from 12 patients producing IFN-γ and FEV 1 (R = -0·860, P = 0·027), and a positive correlation between the percentage of CD8 + T cells expressing HDAC2 and FEV 1 (R = 0·880, P = 0·021, Fig. 1 ).
Representative plots showing IFN-γ/TNF-α and HDAC2 in CD8 + intraepithelial T cells from the large and small airways of a BOS patient are shown in Fig. 2 . Note the significant increase in IFN-γ/TNF-α and decrease in HDAC2 in CD8 + intraepithelial T cells in the small airways compared with the large airways.
Effect of therapies on IFN-γ/TNF-α and HDAC2 expression in CD8 + T cells from blood and small airways
The effect of 5 mg/l theophylline ± 1 µM prednisolone on intracellular IFN-γ synthesis and HDAC2 expression by CD8 + T cells from the blood of 12 patients with BOS is shown in Fig. 3 . No effect on IFN-γ or HDAC2 expression in the presence of theophylline alone was shown. The percentage of CD8 + T cells expressing HDAC2 significantly increased and IFN-γ decreased in the presence of prednisolone. There was a synergistic increase in HDAC2 expression in the presence of theophylline and prednisolone and a corresponding decrease in IFN-γ by CD8 + T cells.
The effect of 5 mg/l theophylline ± 1 µM prednisolone on intracellular IFN-γ synthesis and HDAC2 expression by small airway CD8 + T cells is also shown. No differences in the effects on HDAC2 and IFN-γ expression between blood and small airways from these patients was noted. Representative plots showing IFN-γ and HDAC2 in CD8 + intraepithelial T cells from the small airways of a BOS patient in the presence of 5 mg/l theophylline and 1 µM prednisolone compared with control (no drugs) is shown in Fig. 4 . Note the significant increase in HDAC2 and decrease in IFN-γ in the presence of these drugs compared with control.
Discussion
This is the first study to show a decrease in HDAC2 expression in intraepithelial, proinflammatory lymphocyte subsets in the small airways in patients with BOS. Our current knowledge regarding the cell biology associated with BOS is poor, and any advancement in our understanding of ways to improve patient survival following this diagnosis is of utmost importance. We previously demonstrated compartmentalization of proinflammatory cytokine production by blood and airway T cells of stable transplant patients [14] . A decrease in the cytokine production was noted in blood CD8 + T cells from stable transplant patients (consistent with effective therapeutic control); however, this was not found in BAL or large airway intraepithelial CD8 + T cell airways of these patients, suggesting that the same level of immunosuppression does not occur in the various lung and blood compartments of transplant patients [14] . The present study extended these findings to investigate patients with BOS. We demonstrated that current immunosuppression protocols fail to suppress the production of proinflammatory cytokines in all compartments in these patients. There were no differences in the proinflammatory phenotype of lymphocytes from the blood or small airways, suggesting that these cells may migrate freely between these compartments in these patients.
Importantly, we show that the combination of low dose theophylline and prednisolone exerts similar effects on HDAC2 and IFN-γ expression by CD8 + T cells in blood and small airways ex vivo, suggesting that this combination of therapeutics are similarly effective in both compartments. However, there were only sufficient CD8 + T cells in the small airways of six patients with BOS to perform these analyses, hence further studies in larger numbers of patients with BOS are required to confirm this finding.
Our current findings of increased intraepithelial proinflammatory CD8 + T cells in the small airways compared with the large airways suggest that these cells may also be an important mechanism for small airway insult in BOS. An increase in intraepithelial proinflammatory CD8 + T cells in the small airways of stable transplant correlated with time post-transplant, suggesting that these cells infiltrate and damage the small airways following lung transplant, potentially causing a loss in lung in function even in stable transplants. These findings are consistent with a previous report showing an association between CD8 + T cells in BAL and endobronchial biopsies with time post-transplant and pre-BOS status [15] . A possible limitation of our current work is the relatively small number of BOS patients studied; however, the very close correlation between the percentage of IFN-γ/TNF-α + CD8 + T cells in the blood and small airways of BOS patients and our previous study showing increased numbers of these cells in the blood of BOS patients [7, 8] suggest that these results are an accurate reflection of lymphocyte phenotypes in these patients. Other important limitations in this study include bias linked to different immunosuppression regimens and differences in single versus double transplants for stable versus BOS recipients. Furthermore, the crosssectional nature of the study did not allow longitudinal assessment of HDAC2 in patients. Interestingly, although proinflammatory cytokine production by BAL CD8 + lymphocytes was increased in BOS patients compared with stable patients and controls there was no change in HDAC2, raising the possibility of alternate underlying mechanisms in restrictive allograft syndrome, another major phenotype of chronic allograft dysfunction [16] .
Steroids bind to the GCR and are chaperoned into the cell nucleus, where they recruit HDACs to switch off inflammatory genes [12] . We have recently shown that HDAC2 is reduced in peripheral blood cytotoxic/proinflammatory CD8 + T and NK T-like cells in stable transplant following transplant compared with healthy aged-matched controls [10] . There was a negative correlation between loss of HDAC2 by CD8 + T cells with FEV 1 and time post-transplant, findings similar to those in the current study. Previous studies also showed a correlation between loss of GCR and HDAC2, with an increase in the proinflammatory potential of these cells [10, 17] . We There was no effect on HDAC2 or IFN-γ in the presence of Th alone. There was a significant increase in HDAC2 in the presence of Pred and a synergistic increase in HDAC2 in the presence of Th and Pred (blood: n = 12; small airways: n = 8, median ± standard error of the mean) (*P < 0·05). now show a loss of HDAC2 by CD8 T, NK T-like and NK cells in BAL and large and small airways in stable lung transplant patients, suggesting another mechanism of steroid resistance of these cells. The proinflammatory potential of these cells was further increased in patients with BOS and associated with a further loss of HDAC2. Taken together with our previous studies, our results suggest that measurement of intracellular proinflammatory cytokines and HDAC2 in blood and small airway lymphocyte subsets may be a reliable marker in identifying patients with BOS or impending BOS.
Determining whether the individual proinflammatory cells show a loss of both HDAC2 and GCR would be a worthwhile extension to our study to ascertain whether multiple mechanisms for steroid resistance occur in individual cell types.
Given the relatively inexpensive costs and fewer side effects associated with treating patients with theophylline, our findings argue for a clinical trial with add-on theophylline treatment, especially in patients with early-onset or high-grade-onset BOS [18] . Measurement of proinflammatory cytokines and HDAC2/GCR in CD8 + T cells in blood and small airway brushings following treatment could aid the determination of the effectiveness of this therapy.
In conclusion, BOS is associated with increased intraepithelial proinflammatory CD8 + T, NK T-like and NK cells in the blood, BAL, small and large airways. There was a significant increase in these proinflammatory lymphocytes in the small (compared with large) airways. Treatments that increase HDAC2 in these lymphocyte subsets in the blood, graft and airways in BOS patients may improve graft survival.
